dihexa hgf/c-met potentiator

dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers The HGF/c-Met Axis: A Promising

Name: dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers The HGF/c-Met Axis: A Promising
Brand: sennencoveholidaylets.co.uk
SKU: 9933087528
Price: 29.59 USD
Availability: InStock
Rating: 4.3438 (13 reviews)

The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease What is Dihexa? Benefits, mechanism, and uses for cognitive function Cenegenics Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect

SKU: 9933087528 · From sennencoveholidaylets.co.uk

4.3

USD29.59 USD50.59

Pay in 4 interest-free payments of $7.40 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

EMBO Journal 31, 15061517

The bloodbrain barrier: Structure, regulation and drug delivery

PHHs were cultured according to the providers instructions using all recommended components to ensure appropriate cell integrity and optimal culture conditions

J.WilsonS.HuX

Besides, HSPA1, previously known anti-proliferative factor with JAK/STAT pathway involved, is additionally reported to mediate the angiogenic effect of interleukin-28A in vitro and in vivo via the eNOS/AKT signaling pathway and the activator protein-1/nuclear factor-B/matrix metalloproteinase-2 (AP-1/NF-B/MMP-2) cascade (Song et al., 2025)